Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia | CPRD

Publication Type:

Journal Article

Authors:

Hagberg, K. W.; Divan, H. A.; Fang, S. C.; Nickel, J. C.; Jick, S. S.

Source:

Clin Epidemiol, Volume 9, p.83-91 (2017)